Frank
Bartolini
Senior Vice President, Market Access
Frank Bartolini, MSA joined Liquidia in 2021 where he serves as Senior Vice President of Market Access. With more than 20 years of experience in the biopharmaceuticals industry, Frank brings extensive experience developing and implementing proven tactics to the management of Liquidia’s market access strategy where he supports maximizing the accessibility of new product launches and the value of established products. Previously, Frank worked at Ironshore where he led its market access team from August 2019 to May 2021. Prior to this, Frank was an initial member of the RareGen team where he supported the build-out of the organization and the launch of Treprostinil Injection for pulmonary arterial hypertension (PAH). Frank holds a Master of Science in Accountancy from Western Michigan University and a Bachelor of Science from Central Michigan University.
Frank Bartolini, MSA joined Liquidia in 2021 where he serves as Senior Vice President of Market Access. With more than 20 years of experience in the biopharmaceuticals industry, Frank brings extensive experience developing and implementing proven tactics to the management of Liquidia’s market access strategy where he supports maximizing the accessibility of new product launches and the value of established products. Previously, Frank worked at Ironshore where he led its market access team from August 2019 to May 2021. Prior to this, Frank was an initial member of the RareGen team where he supported the build-out of the organization and the launch of Treprostinil Injection for pulmonary arterial hypertension (PAH). Frank holds a Master of Science in Accountancy from Western Michigan University and a Bachelor of Science from Central Michigan University.